Rainbow Children's Medicare has appointed Sudarshan Patodia as its Chief Financial Officer (CFO) and Group CFO, effective September 23, 2026.

Leadership appointment details

The Board of Directors approved the appointment pursuant to recommendations from the Nomination and Remuneration Committee and the Audit Committee. Patodia assumes the role of Key Managerial Personnel (KMP) with immediate effect.

Professional background

Sudarshan Patodia is a Chartered Accountant and Gold Medalist with nearly two decades of experience in finance across healthcare, retail, and FMCG sectors. His career trajectory includes significant roles in financial strategy and operations.

Prior to joining Rainbow Children's Medicare, he served as the Chief Financial Officer of New Delhi Centre for Sight Limited. In that role, he was responsible for finance, treasury, investor relations, strategic planning, fundraising, and M&A activities, including acquisition transactions.

Before Centre for Sight, Patodia served as Vice President – Finance at Vishal Mega Mart, where he contributed to business finance, FP&A, investor relations, and the company's IPO journey. He also spent approximately 14 years with ITC Limited in corporate and business finance roles, covering treasury, planning, internal audit, and category finance.

Governance updates

In addition to the leadership change, the Board approved amendments to the Policy on Determination of Materiality of Events / Information. The amended policy is available on the company's website for investor reference.

Rainbow Children's Medicare Limited Rainbow Children's Medicare has announced a schedule of in-person meetings with analysts and institutional investors for September 18 to 22, 2026.

The healthcare company will engage with stakeholders at three major financial forums in Mumbai during this period. These interactions are part of the firm's regular investor relations activities under SEBI Listing Regulations.

Meeting Schedule

The company confirmed that no Unpublished Price Sensitive Information (UPSI) will be shared during these engagements. The schedule is subject to change due to exigencies.

Regulatory Disclosure

The intimation was issued pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Shreya Mitra, Company Secretary and Compliance Officer, signed the disclosure on September 11, 2026.

The company's registered office is located in Hyderabad, Telangana.